Falsified Medicines Directive

(Image: Getty/Andrey Bukreev)

Looking to the future of a safe supply chain

By Ben Hargreaves

in-PharmaTechnologist (IPT) speaks to Ettore Cucchetti (EC), CEO of ACGI, about how the biopharma industry is adapting to the threat of counterfeit medicine and how he expects the industry will adopt further measures beyond those stipulated in the EU...

EU reliance on API imports is 'alarming' says EFCG

update

EU reliance on API imports is 'alarming' says EFCG

By Gareth Macdonald

European dependence on drugs and APIs made outside the EU is still ‘alarming’ despite recently introduced anti-falsified meds laws according to the European Fine Chemicals Group (EFCG).

Falsified APIs and gangsters in the pharma industry

Falsified APIs and gangsters in the pharma industry

By Nick Taylor

Guy Villax, board member of the EFCG, talks falsified APIs, EU efforts to tackle the issue, and the presence of gangsters in the pharma industry in an in-PharmaTechnologist video interview.